TELA

Tela Bio Inc

TELA, USA

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

https://www.telabio.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TELA
stock
TELA

New Analyst Forecast: $TELA Given $3 Price Target Quiver Quantitative

Read more →
TELA
stock
TELA

TELA Bio stock price target lowered to $3 by Lake Street on sales issues Investing.com UK

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$3.45

Analyst Picks

Strong Buy

3

Buy

1

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

33.55

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-552.54 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-13.97 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-28.66 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

38.55

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 65.25% of the total shares of Tela Bio Inc

1.

Nantahala Capital Management, LLC

(12.9027%)

since

2025/06/30

2.

Essex Woodlands Health Ventures

(10.3763%)

since

2025/06/30

3.

SILVERARC CAPITAL MANAGEMENT, LLC

(7.0168%)

since

2025/06/30

4.

Stonepine Capital Management Llc

(5.2598%)

since

2025/06/30

5.

Vanguard Group Inc

(4.8252%)

since

2025/06/30

6.

Dafna Capital Management LLC

(3.6375%)

since

2025/06/30

7.

Vanguard Total Stock Mkt Idx Inv

(2.9106%)

since

2025/07/31

8.

Perkins Capital Management Inc

(2.2109%)

since

2025/06/30

9.

Pentwater Capital Management LP

(2.0572%)

since

2025/06/30

10.

Citigroup Inc

(1.8932%)

since

2025/06/30

11.

Velan Capital Investment Management LP

(1.8866%)

since

2025/06/30

12.

Sio Capital Management, LLC

(1.6062%)

since

2025/06/30

13.

BlackRock Inc

(1.1574%)

since

2025/06/30

14.

Vanguard Institutional Extnd Mkt Idx Tr

(1.1324%)

since

2025/07/31

15.

Geode Capital Management, LLC

(0.853%)

since

2025/06/30

16.

UBS Group AG

(0.6198%)

since

2025/06/30

17.

Paradigm Capital Management, Inc.

(0.5048%)

since

2025/06/30

18.

Paradigm Micro-Cap

(0.5048%)

since

2025/08/31

19.

Jacob Small Cap Growth Investor

(0.4645%)

since

2025/06/30

20.

Fidelity Extended Market Index

(0.3977%)

since

2025/07/31

21.

Birchview Capital, LP

(0.3913%)

since

2025/06/30

22.

Jacob Discovery Fd Instl

(0.3907%)

since

2025/06/30

24.

Northern Trust Corp

(0.2374%)

since

2025/06/30

25.

Perkins Discovery

(0.2019%)

since

2025/06/30

26.

iShares Micro-Cap ETF

(0.1808%)

since

2025/08/31

27.

Renaissance Technologies Corp

(0.17%)

since

2025/06/30

28.

Fidelity Total Market Index

(0.1699%)

since

2025/07/31

29.

State Street Corp

(0.16%)

since

2025/06/30

30.

Bridgeway Ultra-Small Company Market

(0.1262%)

since

2025/06/30

31.

Fidelity Series Total Market Index

(0.105%)

since

2025/07/31

32.

NT Ext Equity Mkt Idx Fd - L

(0.0918%)

since

2025/06/30

33.

Northern Trust Extended Eq Market Idx

(0.0918%)

since

2025/06/30

34.

Extended Equity Market Fund K

(0.0865%)

since

2025/06/30

35.

Spartan Extended Market Index Pool F

(0.0864%)

since

2025/07/31

36.

Vanguard Instl Ttl Stk Mkt Idx InstlPls

(0.0742%)

since

2025/07/31

37.

NT Ext Equity Mkt Idx Fd - NL

(0.0692%)

since

2025/06/30

38.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0537%)

since

2025/06/30

39.

Fidelity Nasdaq Composite Index

(0.047%)

since

2025/07/31

40.

Spartan Total Market Index Pool G

(0.0468%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.1556

Latest Release

Date

2025-09-30

EPS Actual

-0.19

EPS Estimate

-0.16

EPS Difference

-0.03

Surprise Percent

-18.75%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1)
Economic Moat
No Clear Moat(2.8)
GARP
Not Attractive for GARP(1)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(1)
Value
Overpriced(1.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.